![Quiver Logo](/static/img/logo-icon.png)
![PSTV logo](https://quiver-logos.s3.us-east-2.amazonaws.com/pstv.png)
PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PSTV Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of PSTV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PSTV's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to PSTV
Recent picks made for PSTV stock on CNBC
ETFs with the largest estimated holdings in PSTV
Flights by private jets registered to PSTV
![Quiver Logo](/static/img/logo-icon.png)